DREADD
Designer receptors exclusively activated by designer drugs (DREADDs) are genetically engineered GPCRs that are activated by physiologically inert synthetic small molecules (designer drugs) but not their endogenous ligand. Read our DREADDs mini-review or for practical advice on using these ligands in the lab see Stability of Water-Soluble DREADD Ligands in Solution: A Technical Review and Clozapine N-Oxide (freebase) - a technical review on stability, solubility and use in the lab).
-
Indole-3-acetamide (HB0341)
Description:Competitive Tryptophan 2-monooxygenase oxidase inhibitor
Purity:>98%
-
-
-
Ionomycin calcium salt (HB1001)
Description:Calcium ionophore. Stimulates cytokine production.
Purity:>98%
-
Ionomycin free acid (HB1002)
Description:Calcium ionophore. Stimulates cytokine production.
Purity:>98%
-
Iperoxo (HB9785)
Description:Potent muscarinic acetylcholine receptor superagonist. Also binds the hM3R-miniGq DREADD receptor.
-
IPTG (HB3941)
Description:Protein expression inducer. Frequently used with X-Gal in cloning procedures.
Purity:>99%
-
IQ 1 (HB3282)
Description:Wnt pathway activator. Maintains ESC pluripotency in Wnt3a treated cells.
Purity:>99%
